FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19633311000001101: Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Dec 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66532701000001118 Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66532801000001110 Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Is a Irinotecan 300mg/15ml solution for infusion vials true Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Has active ingredient Irinotecan true Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient Irinotecan hydrochloride trihydrate false Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient Irinotecan hydrochloride trihydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) 1 vial Has AMP True Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start